PPAR-γ has been established to have anti-inflammatory effects by blocking the activation of the NLRP3 inflammasome and the production of its proinflammatory cytokines in diverse inflammatory diseases: cerebral ischemia [11], spinal cord injury [28], and obesity [12]. Here, PPARG is linked to brain ischemia.